Members

Immunimed Inc.

ImmuniMed Inc. is an innovative, clinical-stage, Research & Development Biopharmaceutical Company. ImmuniMed Inc. develops oral antibody therapy using passive vaccination to treat and prevent gastro-enteric infections. Their technology is designed to utilize chicken eggs as bioreactors to manufacture specific polyclonal antibodies – a new class of biopharmaceuticals.

Contact Info

6-62 Scurfield Blvd. Winnipeg R3Y 1M5 MB Canada
P: 1 204 487 0974
E: dr.pmaiti@nutratechglobal.com

member

Back

PhD in pharmacology helps grad thrive in business

November 22, 2023

Dr. Waylon Hunt took an unusual path to co-founding and leading a lab-based business, Intrinsic Analytics.

Solnul: Scientific advances + international approvals prime prebiotic to ‘become a global household name’

November 16, 2023

With a burgeoning scientific portfolio showing a unique ability to boost Akkermansia and Bifidobacteria levels, new products launching before the end of 2023, and international regulatory approvals, Solnul resistant starch “is primed to further penetrate

Innovate, Protect, Thrive: New ElevateIP Program Plays Crucial Role in the Success of Canadian Start-ups